Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid.

Eleane de OyarzabalLourdes García-GarcíaClaudia Rangel-EscareñoLeticia Ferreyra-ReyesLorena OrozcoMaría Teresa HerreraClaudia CarranzaEduardo SadaEsmeralda Juárez Alfredo Ponce de León-Garduño José Sifuentes-Osornio Robert John Wilkinson Martha Torres

Published in: Journal of immunology research (2019)

Changes in the profiles of USP18, IL2RA, IFNA, CCL4, and CXCL11 expressions during INH treatment in TST-positive individuals, regardless of IGRA status, are potential tools for monitoring latent tuberculosis treatment.

Keyphrases

rheumatoid arthritis
emergency department
poor prognosis
combination therapy
hiv aids
disease activity
long non coding rna
ankylosing spondylitis
human immunodeficiency virus
adverse drug